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cultures confirmed coccidioidomycosis. Pericardio-
centesis revealed bloody fluid with a red cell count
of 1.1  1012/L, a white cell count of 9.6  109/L,
and a differential of 79% monocytes, 19% neutro-
phils, and 2% eosinophils. The protein was 6 g/dL,
and LDH was 1337 U/L (serum LDH, 248 U/L). Fungal
cultures from the fluid were negative. She was
treated with intravenous amphotericin B with reso-
lution of disease activity over a 12-month period,
and was subsequently placed on continuous treat-
ment with fluconazole 400 mg po, daily (verbal
communication, Crum NF). Surgical intervention
was not required and there has not been a relapse
over a 4-year follow-up period.2
This is the 18th case of CP in the medical litera-
ture. The presentation can be acute, progressing
rapidly to effusive—constrictive physiology or the
presentation can be that of a chronic constrictive
process. The current patient presented with chest
pain and dyspnea, a symptom complex similar to
previously reported patients with CP. What has not
been detailed previously is a bloody pericardial
effusion and female sex (presumably prepubertal).
The favorable outcome was also expected as the
patient did not have disseminated disease nor did
she develop pericardial constriction in need of sur-
gical intervention.
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The incidence of human rabies in Turkey has
decreased significantly. In 2003, only one human
case was reported.1 There is a national rabies
prophylaxis guideline which is mostly based on
World Health Organization and the Advisory Com-
mittee on Immunization Practices recommenda-
tions.2,3 Post-exposure treatment including cell
culture vaccines and equine rabies immunoglobulin
(RIG) is free of charge. Human rabies immunoglo-
bulin (RIG) is very expensive and sometimes both
types of immunoglobulin are not readily available
when needed. In this study we compared the rabies
antibody titers achieved by two different post-
exposure prophylaxis regimens; RIG and five-dose
standard vaccination versus a 2-1-1-dose vaccina-
tion schedule.
Patients were selected from the outpatient clinic
of the Ankara Training and Research Hospital, Depart-
ment of Infectious Diseases and Clinical Microbiology,
admitted between September and December 2001.Patients bitten by a suspect animal were treated
according to the class of exposure described by the
Turkish Republic Ministry of Health Rabies Prophylaxis
Guidelines.4 Patients with class III exposure were
treated preferably with RIG (Rabies Antiserum Berna,
Switzerland) infiltratedaround thewounds and afive-
dose vaccination (Verorab, Pasteur-Merieux) on days
0, 3, 7, 14 and 28, (Group I). A 2-1-1-dose vaccination
schedule was applied to those patients where either
RIG could not be used orwho had been admitted from
an area of low endemic rabies, on days 0 (two doses,
different sites), 7 and 21 (Group II). Patients who had
an underlying disease or medication history or had
previously been vaccinated were excluded from the
study. Blood samples were collected, with the
patient’s permission, on the 7th and 30th days follow-
ing the first dose of vaccine. Serum rabies antibodies
were detected by ELISA (Platelia Rabies Kit, Bio-Rad,
France) according to themanufacturer’s instructions.
The cut-off value was 0.5 IU/ml.
There were 43 patients in Group I and 42 patients
in Group II. The results and some features of the
patients are shown in Table 1. Although the sero-
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Table 1 The features and seroconversion rates of
patients receiving post-exposure rabies prophylaxis.
Group I
(n = 43)
Group
II (n = 42)
Male/Female 26/17 33/9
Mean age, years (range) 32.0
(16—66)
38.1
(16—73)
Admission from
Urban area 36 30
Rural area 7 12
Location of bite
Head and neck — 3
Upper extremity 25 22
Lower extremity 18 17
Time taken to admission
0—1 days 29 31
2 days 14 11
Seroconversion rate
7th day 30% 53%
30th day 90% 95%conversion rate on the 7th day was 1.76 times
greater in Group II than in Group I, this was not
statistically significant (Fisher’s Chi-square test)
( p > 0.05). At day 30, seroconversion rates had
reached the same levels.
Parviz et al.5 note the importance of vaccine
safety in their report. As well as this, seroconver-
sion rates of both regimens may be inadequate in
the early period of post-exposure as found in our
study, and prompt local wound care and early
initiation of treatment might be lifesaving. In
the absence of RIG, applying a 2-1-1-dose vacci-
nation may be an alternative to the standard
vaccination.
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